文献
J-GLOBAL ID:201802275419706337
整理番号:18A0404100
Nrf2は肝星状細胞におけるJAK2/STAT3シグナル伝達に及ぼすSOCS3依存性負のフィードバックループを介して脂肪細胞表現型を誘導する【Powered by NICT】
Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells
著者 (21件):
Lu Chunfeng
(Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Lu Chunfeng
(Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Lu Chunfeng
(Jiangsu Key Laboratory of Therapeutic material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Lu Chunfeng
(Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Xu Wenxuan
(Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Xu Wenxuan
(Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Xu Wenxuan
(Jiangsu Key Laboratory of Therapeutic material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Xu Wenxuan
(Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Shao Jiangjuan
(Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Shao Jiangjuan
(Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Shao Jiangjuan
(Jiangsu Key Laboratory of Therapeutic material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Shao Jiangjuan
(Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zhang Feng
(Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zhang Feng
(Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zhang Feng
(Jiangsu Key Laboratory of Therapeutic material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zhang Feng
(Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Chen Anping
(Department of Pathology, School of Medicine, Saint Louis University, St Louis, MO, USA)
,
Zheng Shizhong
(Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zheng Shizhong
(Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zheng Shizhong
(Jiangsu Key Laboratory of Therapeutic material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
,
Zheng Shizhong
(Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China)
資料名:
International Immunopharmacology
(International Immunopharmacology)
巻:
49
ページ:
203-211
発行年:
2017年
JST資料番号:
T0026B
ISSN:
1567-5769
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)